P Pignatti
Overview
Explore the profile of P Pignatti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coperchini F, Greco A, Petrosino E, Croce L, Teliti M, Marchesi N, et al.
J Endocrinol Invest
. 2024 Jun;
48(1):53-65.
PMID: 38900374
Background: Thyroid cancer is the most common endocrine malignancy. Current therapies are successful, however some patients progress to therapeutically refractive disease. The immunotherapeutic potential of the CXCL8-chemokine/CXCR2-chemokine-receptor system is currently...
2.
Zappa M, Grossi S, Pignatti P, Pini L, Centis R, Migliori G, et al.
Int J Tuberc Lung Dis
. 2024 Apr;
28(5):225-230.
PMID: 38659141
<sec id="st1"><title>INTRODUCTION</title>Alpha-1 antitrypsin (AAT) deficiency, an autosomal co-dominant condition, decreases protein concentration and activity at both serum and tissue levels. Few studies investigated whether the type of gene phenotype in...
3.
Asero R, Brusca I, Cecchi L, Pignatti P, Pravettoni V, Scala E, et al.
Eur Ann Allergy Clin Immunol
. 2021 Jun;
54(5):198-206.
PMID: 34092069
Based on the cross-reactivity between pollen lipid transfer proteins (LTPs) and the peach LTP, Pru p 3, it has been suggested that the pollen might initiate the LTP sensitization process....
4.
Zampogna E, Ambrosino N, Centis R, Cherubino F, Migliori G, Pignatti P, et al.
Int J Tuberc Lung Dis
. 2021 Mar;
25(3):215-221.
PMID: 33688810
The 6-min walking test (6MWT) is responsive to physiological changes and pulmonary rehabilitation (PR) in patients with asthma. The minimal clinically important difference (MCID) has not been established yet. To...
5.
Zampogna E, Migliori G, Centis R, Cherubino F, Facchetti C, Feci D, et al.
Pulmonology
. 2021 Jan;
27(5):452-455.
PMID: 33454281
No abstract available.
6.
Coperchini F, Croce L, Pignatti P, Ricci G, Gangemi D, Magri F, et al.
J Endocrinol Invest
. 2020 Dec;
44(8):1625-1635.
PMID: 33315184
Purpose: Per- and poly-fluoroalkyl-substances (PFASs) are synthetic compounds that raised concern due to their potential adverse effects on human health. Long-chain PFAS were banned by government rules in many states,...
7.
Pignatti P, Visca D, Cherubino F, Zampogna E, Spanevello A
Int J Tuberc Lung Dis
. 2020 Nov;
24(11):1217-1219.
PMID: 33172533
No abstract available.
8.
Visca D, Pignatti P, Spanevello A, Lucini E, La Rocca E
Pharmacol Res
. 2018 Oct;
137:230-235.
PMID: 30312663
Diabetes is a common metabolic disorder affecting the entire body with high morbidity and mortality worldwide. The major complications related to diabetes are mostly due to the macrovascular and microvascular...
9.
Scala E, Villalta D, Uasuf C, Pignatti P, Pirrotta L, Guerra E, et al.
Eur Ann Allergy Clin Immunol
. 2018 Jul;
50(5):217-225.
PMID: 30039692
The development of recombinant technology supported the allergy diagnostic work-up in the daily clinical practice, representing a useful tool for epidemiological studies. An atlas of the IgE sensitization profiles found...
10.
Awwad O, Coperchini F, Pignatti P, Denegri M, Massara S, Croce L, et al.
J Endocrinol Invest
. 2018 Mar;
41(11):1275-1282.
PMID: 29546654
Purpose: The AMPK-activator AICAR recently raised great interest for its anti-cancer properties. With specific regard to thyroid cancer, AICAR reduces cancer cell growth, invasion and metastasis. CXCL8, a chemokine with...